Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Aptah Bio logo — The next generation of RNA therapeutics for age-related dise...

Aptah Bio

The next generation of RNA therapeutics for age-related diseases

Founded 2019 United States San Carlos, United States 12 employees Seed Total: $3.40M Biotechnology, Health and Wellness +3

General Information

Company Name Aptah Bio
Founded Year 2019
Location United States San Carlos, United States +1
Founders / Decision Makers
Team member
Employees 12
Industries Biotechnology, Health and Wellness, Life Sciences +2
Funding Stage Seed
Social

Get notified when Aptah Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Aptah Bio

Aptah Bio, founded in 2019 and headquartered in the United States, is making strides in the biotechnology and pharmaceutical sectors. The company's slogan, "The next generation of RNA therapeutics for age-related diseases," encapsulates its mission to eradicate ailments associated with aging.

With a strategic aim to transform the healthcare landscape, Aptah Bio has developed an innovative therapy that serves as a genome-wide transcription modulator. This pioneering compound is the first of its kind, designed to correct various mRNAs and toxic proteins, potentially revolutionizing treatments for age-related diseases.

The company's recent progress was bolstered by a $3.40M Seed Round investment from Vesper Ventures SA on January 20, 2021. Positioned at the intersection of biotechnology, health, and life sciences, Aptah Bio stands primed to capture a stake in a multi-billion dollar market by addressing critical health challenges.

Taxonomy: RNA therapeutics, Age-related diseases, Neurodegenerative diseases, Pharmaceuticals, Biopharmaceuticals, Genome-wide transcription modulation, Patent attorneys, Biotech startup, Economic impact, Global health, Aging population, Epidemiology, Investment potential

Services & Products

Developing RNA-based therapies
Restoring transcription fidelity
Reducing tumor heterogeneity
Enhancing existing cancer therapies

Target Customers

Oncologists Cancer treatment centers Pharmaceutical companies Biotechnology investors Patients with aggressive cancer types

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
20 Jan 2021

Aptah Bio Alternatives & Competitors

View All Alternatives
Aptah Bio vs
Vandria SA
Vandria SA Switzerland

We develop first-in-class mitophagy inducers that rejuvenate cells to treat age-related and chronic...

Grant
14 employees
Manufacturing, Pharmaceutical
Aptah Bio vs
Juvena Therapeutics
Juvena Therapeutics United States

Decoding Secreted Proteins

Series A
44 employees
Aptah Bio vs
Deciduous Therapeutics
Deciduous Therapeutics United States

Deciduous is developing a novel class of immune-modulatory therapies designed to promote a healthy l...

Seed
12 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Aptah Bio

The next generation of RNA therapeutics for age-related diseases
Aptah Bio was founded in 2019.
Aptah Bio is headquartered in San Carlos, United States.
Aptah Bio operates in the following industries: Biotechnology, Health and Wellness, Life Sciences, Pharmaceutical, Clean Energy.
Aptah Bio has approximately 12 employees.
Aptah Bio has completed 1 funding round, raising a total of $3.40M. The latest funding stage is Seed.
Aptah Bio offers: Developing RNA-based therapies, Restoring transcription fidelity, Reducing tumor heterogeneity, Enhancing existing cancer therapies.
Top alternatives and competitors to Aptah Bio include Vandria SA, Juvena Therapeutics, Deciduous Therapeutics, Biophysical Therapeutics, Cosmica Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aptah Bio and Vandria SA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aptah Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy